BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33067554)

  • 1. Left ventricular remodeling and dysfunction in primary aldosteronism.
    Tsai CH; Pan CT; Chang YY; Chen ZW; Wu VC; Hung CS; Lin YH
    J Hum Hypertens; 2021 Feb; 35(2):131-147. PubMed ID: 33067554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac Remodeling in Patients With Primary and Secondary Aldosteronism: A Tissue Doppler Study.
    Cesari M; Letizia C; Angeli P; Sciomer S; Rosi S; Rossi GP
    Circ Cardiovasc Imaging; 2016 Jun; 9(6):. PubMed ID: 27307552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A Propensity Score-Matching Follow-Up Study With Tissue Doppler Imaging.
    Chang YY; Liao CW; Tsai CH; Chen CW; Pan CT; Chen ZW; Chen YL; Lin LC; Chang YR; Wu VC; Wu KD; Hung CS; Lin YH; ;
    J Am Heart Assoc; 2019 Nov; 8(22):e013263. PubMed ID: 31718437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and Non-Hemodynamic Components of Cardiac Remodeling in Primary Aldosteronism.
    Pan CT; Wu XM; Tsai CH; Chang YY; Chen ZW; Chang CC; Lee BC; Liao CW; Chen YL; Lin LC; Chang YR; Hung CS; Lin YH
    Front Endocrinol (Lausanne); 2021; 12():646097. PubMed ID: 33953695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone induces left ventricular subclinical systolic dysfunction: a strain imaging study.
    Chen ZW; Huang KC; Lee JK; Lin LC; Chen CW; Chang YY; Liao CW; Wu VC; Hung CS; Lin YH;
    J Hypertens; 2018 Feb; 36(2):353-360. PubMed ID: 28902663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism.
    Rossi GP; Cesari M; Cuspidi C; Maiolino G; Cicala MV; Bisogni V; Mantero F; Pessina AC
    Hypertension; 2013 Jul; 62(1):62-9. PubMed ID: 23648698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus is associated with more adverse non-hemodynamic left ventricular remodeling and less recovery in patients with primary aldosteronism.
    Chen UL; Liao CW; Wang SM; Lai TS; Huang KH; Chang CC; Lee BC; Lu CC; Chang YR; Chang YY; Hung CS; Chueh JS; Wu VC; Tsai CH; Lin YH;
    J Investig Med; 2023 Feb; 71(2):101-112. PubMed ID: 36647318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.
    Garcia AG; Wilson RM; Heo J; Murthy NR; Baid S; Ouchi N; Sam F
    Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H587-96. PubMed ID: 22730392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical Primary Aldosteronism and Cardiovascular Health: A Population-Based Cohort Study.
    Hundemer GL; Agharazii M; Madore F; Vaidya A; Brown JM; Leung AA; Kline GA; Larose E; Piché ME; Crean AM; Shaw JLV; Ramsay T; Hametner B; Wassertheurer S; Sood MM; Hiremath S; Ruzicka M; Goupil R
    Circulation; 2024 Jan; 149(2):124-134. PubMed ID: 38031887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular systolic function in primary aldosteronism and hypertension.
    Rossi GP; Sacchetto A; Pavan E; Scognamiglio R; Pietra M; Pessina AC
    J Hypertens; 1998 Dec; 16(12 Pt 2):2075-7. PubMed ID: 9886899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldosterone-Related Myocardial Extracellular Matrix Expansion in Hypertension in Humans: A Proof-of-Concept Study by Cardiac Magnetic Resonance.
    Redheuil A; Blanchard A; Pereira H; Raissouni Z; Lorthioir A; Soulat G; Vargas-Poussou R; Amar L; Paul JL; Helley D; Azizi M; Kachenoura N; Mousseaux E
    JACC Cardiovasc Imaging; 2020 Oct; 13(10):2149-2159. PubMed ID: 32950448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between urine aldosterone and diastolic function in patients with primary aldosteronism and essential hypertension.
    Chang YY; Lee HH; Hung CS; Wu XM; Lee JK; Wang SM; Liao MT; Chen YH; Wu VC; Wu KD; Lin YH;
    Clin Biochem; 2014 Sep; 47(13-14):1329-32. PubMed ID: 24892901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Echocardiographic Changes Between Surgery and Medication Treatment in Patients With Primary Aldosteronism.
    Ueda T; Tsurutani Y; Osada J; Inoue K; Hoshino Y; Ono M; Nakai K; Saito J; Yumoto K; Nishikawa T
    J Am Heart Assoc; 2022 Jul; 11(13):e023813. PubMed ID: 35766291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy.
    Lin YH; Lee HH; Liu KL; Lee JK; Shih SR; Chueh SC; Lin WC; Lin LC; Lin LY; Chung SD; Wu VC; Kuo CC; Ho YL; Chen MF; Wu KD;
    Surgery; 2011 Sep; 150(3):526-33. PubMed ID: 21514614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anatomical and functional remodeling of left ventricle in patients with primary aldosteronism and concomitant albuminuria.
    Kao TW; Wu XM; Liao CW; Tsai CH; Chen ZW; Chang YY; Lee BC; Chiu YW; Lai TS; Wu VC; Lin YH; Hung CS;
    Ther Adv Chronic Dis; 2023; 14():20406223221143253. PubMed ID: 36860935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone and Left Ventricular Remodeling.
    Catena C; Colussi G; Brosolo G; Novello M; Sechi LA
    Horm Metab Res; 2015 Dec; 47(13):981-6. PubMed ID: 26566103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMR-Verified Myocardial Fibrosis Is Associated With Subclinical Diastolic Dysfunction in Primary Aldosteronism Patients.
    Zhou F; Wu T; Wang W; Cheng W; Wan S; Tian H; Chen T; Sun J; Ren Y
    Front Endocrinol (Lausanne); 2021; 12():672557. PubMed ID: 34054733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortisol Excess in Patients With Primary Aldosteronism Impacts Left Ventricular Hypertrophy.
    Adolf C; Köhler A; Franke A; Lang K; Riester A; Löw A; Heinrich DA; Bidlingmaier M; Treitl M; Ladurner R; Beuschlein F; Arlt W; Reincke M
    J Clin Endocrinol Metab; 2018 Dec; 103(12):4543-4552. PubMed ID: 30113683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fenofibrate on cardiac remodeling in aldosterone-induced hypertension.
    Lebrasseur NK; Duhaney TA; De Silva DS; Cui L; Ip PC; Joseph L; Sam F
    Hypertension; 2007 Sep; 50(3):489-96. PubMed ID: 17606858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.